ClinicalTrialsFinder

Patients With Advanced Non-small Cell Lung Cancer With Meningeal Progression After Osimertinib Treatment Clinical Trials in Shengyang, City

1 recruitingShengyang, City, China

Showing 1–1 of 1 trials

Recruiting
Phase 1

Zorifertinib With Osimertinib for NSCLC With Meningeal Progression

Patients With Advanced Non-small Cell Lung Cancer With Meningeal Progression After Osimertinib Treatment
Alpha Biopharma (Jiangsu) Co., Ltd.42 enrolled5 locationsNCT07361705